MK-677 25MG | 30 UNITS

CARDARINE (GW501516) — 20 mg

PPARδ Pathway Research Compound

Capsules — 60 Count

Cardarine (GW501516) is a research compound frequently studied for its interaction with PPARδ signaling pathways associated with lipid metabolism, cellular energy utilization, and metabolic regulation models.

Cardarine has been examined in laboratory environments investigating fatty acid oxidation processes, endurance-related signaling pathways, and metabolic efficiency frameworks.

This compound is commonly researched in experimental models evaluating regulatory pathways involved in energy expenditure, lipid utilization, and metabolic signaling mechanisms.

Researchers may utilize this compound in studies examining:

• Lipid metabolism pathway research

• Energy utilization signaling models

• Endurance pathway investigation

• Fatty acid oxidation research

• Metabolic regulatory pathways

Each capsule contains a precisely measured quantity to support consistency across laboratory applications and controlled experimental protocols.

Capsule Specifications

Quantity: 60 Capsules

Per Capsule:

Cardarine (GW501516) — 20 mg

Research Use Notice

FOR RESEARCH USE ONLY.

Not for human or veterinary consumption.

Not a drug, food, or cosmetic.

Not evaluated by the FDA.

Purchaser assumes responsibility for safe handling and compliance with applicable laws and regulations.